secwatch / observer
8-K filed June 8, 2023, 7:59 PM ET ticker MMSI CIK 0000856982
M&A confidence high sentiment positive materiality 0.80

Merit Medical acquires two product portfolios for $132.5M; updates 2023 guidance

MERIT MEDICAL SYSTEMS INC

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MERIT MEDICAL SYSTEMS INC updated its full-year 2023 guidance (reaffirmed).

Period
full-year 2023
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
Merit re-affirms full-year 2023 financial guidance on stand-alone basis and updates full-year 2023 financial guidance to include partial-year impact from acquisitions
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MERIT MEDICAL SYSTEMS INC entered into Purchase Agreement with AngioDynamics, Inc. valued at $100 million (effective 2023-06-08).

Action
entry
Agreement
asset purchase
Counterparty
AngioDynamics, Inc.
Value
$100 million
Effective
2023-06-08
Exact text from the filing
On June 8, 2023, Merit entered into an Asset Purchase Agreement (the “Purchase Agreement”) with AngioDynamics, Inc., a Delaware corporation (“AngioDynamics”), pursuant to which Merit acquired a portfolio of dialysis catheter products, including various assets related thereto, and the BioSentry ® Biopsy Tract Sealant System from AngioDynamics (collectively, the “Acquisition”).
View on SEC.gov

Browse all earnings releases →

MERIT MEDICAL SYSTEMS INC filing history →

Source: SEC EDGAR
accession 0000856982-23-000039
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.